(PharmaNewsWire.Com, February 19, 2019 ) The Hospital Acquired Disease Testing Market report aims to provide a 360-degree view of the market in terms of cutting-edge technology, key developments, drivers, restraints and future trends with impact analysis of these trends on the market for short-term, mid-term and long-term during the forecast period. Further, the report also covers key players profiling with detailed SWOT analysis, financial facts and key developments of products/service from the past three years.
North America dominated the hospital-acquired disease testing market in 2017, owing rising awareness among the patient population as well as developing healthcare infrastructure. Asia Pacific on the other hand is expected witness the highest growth over the forecast period in the hospital-acquired disease testing market owing to the availability of immense opportunities in countries like India, China & Japan. Sanitation problems in the healthcare facilities and increasing number of hospitals admissions are expected to be the driving factors for Asian growth.
Hospital acquired infections are caused due to viral, fungal and bacterial pathogens. A nosocomial infection also referred to as hospital-acquired infections occurs because of an infectious agent or toxin that exists in certain location of a medical facility. One of the most common wards where HAIs occur is the intensive care unit (ICU), where doctors treat serious diseases. Hospital-acquired diseases continue to be a major concern for healthcare industry.
1. INTRODUCTION 1.1. SCOPE OF STUDY 1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
2. KEY TAKEAWAYS
3. HOSPITAL-ACQUIRED DISEASE TESTING MARKET LANDSCAPE 3.1. MARKET OVERVIEW 3.2. MARKET SEGMENTATION 3.2.1. Hospital-Acquired Disease Testing Market - By Test Type 3.2.2. Hospital-Acquired Disease Testing Market - By End User 3.2.3. Hospital-Acquired Disease Testing Market - By Region 3.2.3.1. By Country 3.3. PEST ANALYSIS 3.3.1. North America - PEST Analysis 3.3.2. Europe - PEST Analysis 3.3.3. Asia Pacific - PEST Analysis 3.3.4. Middle East and Africa - PEST Analysis 3.3.5. South and Central America- PEST Analysis
The market for hospital-acquired disease testing market is expected to witness growth due to increasing number of patients suffering with hospital-acquired infections. Moreover, advancing healthcare infrastructures with introduction of infection surveillance solutions and systems suggesting risks and action plans to manage these diseases are further expected to drive the growth of the market. However, inadequate security in healthcare facilities and lack of funding in developing and under-developed economies are likely to hinder hospital-acquired disease testing market growth.
The global hospital-acquired disease testing market is segmented on the basis of test type and end user. On the basis of test type, the global hospital-acquired disease testing market is segmented into UTI tests, SSI tests, pneumococcal infection tests, bloodstream infection tests, and MRSA tests. Based on end user, the hospital-acquired disease testing market is segmented into hospitals, clinics, ambulatory surgical centers, and community health centers.
The hospital-acquired disease testing market report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global hospital-acquired disease testing market based test type and end user. It also provides market size and forecast till 2027 for overall hospital-acquired disease testing market with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 13 counties globally along with current trend and opportunities prevailing in the region.
Some of the key players influencing the market are Thermo Fisher Scientific Inc., Diatherix Eurofins, LLC, QIAGEN, Meridian Bioscience, Inc., Nordion (Canada) Inc., F. Hoffmann La Roche Ltd, Cantel Medical, Cepheid, Clinical Lab Products, and McKesson Medical-Surgical Inc. among others.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
